Immucell (ICCC) Amortizatization of Intangibles (2010 - 2024)
Immucell's (ICCC) quarterly Amortizatization of Intangibles came in at $5223.0 in Q2 2024, little changed on a QoQ basis from $5223.0 in Q1 2024.
Immucell (ICCC) Amortizatization of Intangibles (2010 - 2024) Analysis & Trends
Immucell (ICCC) has 15 years of Amortizatization of Intangibles data on file, last reported at $5223.0 in Q2 2024.
- Quarterly Amortizatization of Intangibles changed N/A year-over-year to $5223.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $20445.0 (changed N/A YoY) and the FY2023 annual result came in at $9547.0, down 50.03% from the prior year.
- Amortizatization of Intangibles steadied at $5223.0 in Q2 2024, from $5223.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $5223.0 in Q4 2023 to a low of $4776.0 in Q1 2020.
- A 5-year average of $4859.8 and a median of $4776.0 in 2020 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2020 — Amortizatization of Intangibles changed 0.0% — and 2023, when it rose 9.36%.
- Tracing ICCC's Amortizatization of Intangibles over 5 years: stood at $4776.0 in 2020, then changed by 0.0% to $4776.0 in 2021, then changed by 0.0% to $4776.0 in 2022, then climbed by 9.36% to $5223.0 in 2023, then changed by 0.0% to $5223.0 in 2024.
- The last three Amortizatization of Intangibles figures came in at $5223.0 (Q2 2024), $5223.0 (Q1 2024), and $5223.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Immucell | 91.19 Mn | 82.33 Mn | 2.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 5,223.00 |
| Jun 30, 2024 | 5,223.00 |
| Mar 31, 2024 | 5,223.00 |
| Mar 31, 2024 | 5,223.00 |
| Dec 31, 2023 | 5,223.00 |
| Dec 31, 2023 | 5,223.00 |
| Mar 31, 2023 | 4,776.00 |
| Mar 31, 2023 | 4,776.00 |
| Dec 31, 2022 | 4,776.00 |
| Dec 31, 2022 | 4,776.00 |
| Sep 30, 2022 | 4,776.00 |
| Sep 30, 2022 | 4,776.00 |
| Jun 30, 2022 | 4,776.00 |
| Jun 30, 2022 | 4,776.00 |
| Mar 31, 2022 | 4,776.00 |
| Mar 31, 2022 | 4,776.00 |
| Dec 31, 2021 | 4,776.00 |
| Dec 31, 2021 | 4,776.00 |
| Sep 30, 2021 | 4,776.00 |
| Sep 30, 2021 | 4,776.00 |